Sofiva Genomics

Taipei, Taiwan Founded: 2012 • Age: 14 yrs
Provides prenatal and neonatal genetic screening tests for accurate health assessments.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Sofiva Genomics

Sofiva Genomics is a company based in Taipei (Taiwan) founded in 2012. It operates as a B2B. Sofiva Genomics operates in a competitive market with competitors including Natera, SYNLAB, Progenity, Sequenom and Ariosa Diagnostics, among others.

  • Headquarter Taipei, Taiwan
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $453.31 M
    -2.89
    as on Dec 31, 2024
  • Net Profit
    $18.43 M
    59.89
    as on Dec 31, 2024
  • EBITDA
    $38.24 M
    50.22
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sofiva Genomics

Premium access

Detailed funding history for Sofiva Genomics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sofiva Genomics

Investments
Premium access

Investment portfolio details for Sofiva Genomics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sofiva Genomics

Premium access

Detailed financials for Sofiva Genomics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sofiva Genomics Comparisons

Sofiva Genomics Primary company
Description
Provides prenatal and neonatal genetic screening tests for a...
Location
Taipei, Taiwan
Founded Year
2012
Annual Revenue
$453.31 M
Net Profit
$18.43 M
EBITDA
$38.24 M
Employees
Not available
Premium access

Peer comparison for Sofiva Genomics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sofiva Genomics

Sofiva Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, SYNLAB, Progenity, Sequenom and Ariosa Diagnostics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
Provider of medical diagnosis and clinical laboratory analysis services
Locked Locked Locked
Non-invasive prenatal genomic testing is provided for genetic disorders.
Locked Locked Locked
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
Locked Locked Locked
Molecular diagnostics for prenatal genetic testing are specialized in.
Locked Locked Locked
NGS-based diagnostic solutions for neonatal screening are developed.
Premium access

Detailed competitors of Sofiva Genomics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sofiva Genomics

Premium access

Complete news archive for Sofiva Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sofiva Genomics

Sofiva Genomics was founded in 2012.

Sofiva Genomics is headquartered in Taipei, Taiwan.

Sofiva Genomics provides prenatal and neonatal genetic screening tests for accurate health assessments, focusing on providing healthcare solutions, advancing biotech innovations, genetic testing, and prenatal and neonatal. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Sofiva Genomics's top competitors include Natera, SYNLAB and IdentifAI.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available